Institutional Development Award (IDeA) for Clinical & Translational Research (CTR)

The Institutional Development Award for Clinical and Translational Research program, solicitation PAR-27-056, is a limited competition funding opportunity from the National Institutes of Health designed to build biomedical research capacity in states that have historically received low levels of NIH funding. The program operates through two distinct tracks: the Clinical and Translational Research Development track, which focuses on workforce development and infrastructure for organizations with limited capacity, and the Clinical and Translational Research Network track, which supports statewide or multi-state networks to expand existing infrastructure and coordinate research activities. The primary goal is to enable research on diseases and health challenges prevalent in IDeA states through the establishment of foundational cores for administration, professional development, community engagement, and research design. Funding is structured over a maximum project period of five years, with direct cost limits varying by track. The Development track allows up to 1 million dollars in year one and 1.75 million dollars annually in years two through five. The Network track allows up to 3 million dollars in year one and 3.5 million dollars annually in years two through five. Applications are evaluated based on scientific and technical merit through a peer review system, focusing on significance, investigator suitability, and the potential to address urgent health concerns for the state population. Eligible applicants include a wide range of organizations, such as higher education institutions, nonprofits, and government entities, provided they maintain active registration in the System for Award Management. Awardees must adhere to strict human subjects research standards, Good Clinical Practice principles, and specific cybersecurity incident reporting requirements.